The Inflammation Insights Study

We’re conducting a clinical trial to compare two formulations of a potential new treatment, Asengeprast, in healthy adult volunteers. This treatment is being developed for future use in conditions involving inflammation and fibrosis, such as chronic kidney disease and Systemic Sclerosis (a connective tissue disorder that can cause fibrosis (thickening) to the skin and internal organs).